HomeCompareAWLIF vs JNJ

AWLIF vs JNJ: Dividend Comparison 2026

AWLIF yields 487.80% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AWLIF wins by $50753.86M in total portfolio value
10 years
AWLIF
AWLIF
● Live price
487.80%
Share price
$0.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50753.89M
Annual income
$36,168,404,531.85
Full AWLIF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — AWLIF vs JNJ

📍 AWLIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAWLIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AWLIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AWLIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AWLIF
Annual income on $10K today (after 15% tax)
$41,463.41/yr
After 10yr DRIP, annual income (after tax)
$30,743,143,852.07/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, AWLIF beats the other by $30,743,139,866.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AWLIF + JNJ for your $10,000?

AWLIF: 50%JNJ: 50%
100% JNJ50/50100% AWLIF
Portfolio after 10yr
$25376.96M
Annual income
$18,084,204,610.63/yr
Blended yield
71.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AWLIF
No analyst data
Altman Z
1.4
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AWLIF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAWLIFJNJ
Forward yield487.80%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$50753.89M$30.3K
Annual income after 10y$36,168,404,531.85$4,689.40
Total dividends collected$49478.61M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AWLIF vs JNJ ($10,000, DRIP)

YearAWLIF PortfolioAWLIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$59,480$48,780.49$10,592$272.30+$48.9KAWLIF
2$334,811$271,167.03$11,289$357.73+$323.5KAWLIF
3$1,784,770$1,426,522.08$12,123$472.89+$1.77MAWLIF
4$9,016,553$7,106,848.63$13,141$629.86+$9.00MAWLIF
5$43,202,271$33,554,559.81$14,408$846.81+$43.19MAWLIF
6$196,483,123$150,256,693.49$16,021$1,151.60+$196.47MAWLIF
7$848,895,486$638,658,543.63$18,122$1,588.22+$848.88MAWLIF
8$3,487,095,949$2,578,777,778.75$20,930$2,228.20+$3487.08MAWLIF
9$13,631,297,985$9,900,105,319.66$24,792$3,191.91+$13631.27MAWLIF
10$50,753,893,375$36,168,404,531.85$30,274$4,689.40+$50753.86MAWLIF

AWLIF vs JNJ: Complete Analysis 2026

AWLIFStock

Ameriwest Lithium Inc. engages in the acquisition, exploration, and development of natural resources properties in Canada and the United States. The company focuses on exploring Nevada's Deer Musk East property consists of 283 claims covering an area of 5,500 acres located in the prolific Clayton Valley; the Railroad Valley property comprising 462 claims covering an area of approximately 9,097 acres; the Edwards Creek Valley consists of 1,243 contiguous claims covering an area of 22,200 acres; and the Thompson Valley property covering an area of 2,859 acres located in Yavapai County. Its resource portfolio includes the ESN project located in White Pine County, Nevada; the Koster Dam property located in the Clinton Mining Division of British Columbia; and Quet and Fire property located in Canada. The company was formerly known as Oakley Ventures Inc. and changed its name to Ameriwest Lithium Inc. in April 2021. Ameriwest Lithium Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full AWLIF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AWLIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AWLIF vs SCHDAWLIF vs JEPIAWLIF vs OAWLIF vs KOAWLIF vs MAINAWLIF vs ABBVAWLIF vs MRKAWLIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.